Advancing Care Through Epigenomics

Thursday, September 13
1:30 PM - 3:00 PM

Learning Objectives:

Tamas Ordog, MD

Associate Professor of Physiology, College of Medicine and Science
Center for Individualized Medicine
Mayo Clinic
Rochester, Minnesota

Tamas Ordog, MD is a Consultant and Associate Professor in the Department of Physiology and Biomedical Engineering and the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota, and founding Director of the Epigenomics Program of the Mayo Clinic Center for Individualized Medicine (CIM). He received predoctoral training in molecular endocrinology at the University of Pécs, Hungary and postdoctoral training in integrative neuroendocrinology at The University of Texas – Houston Health Science Center. Dr. Ordog has studied the cellular and molecular basis of gastrointestinal neuromuscular control in health and disease since 1998. His current research interests include the epigenetic control of cellular phenotypes in the lineage of gastrointestinal pacemaker/neuromodulator cells in aging, diabetes, caloric restriction and oncogenesis and in response to targeted oncolytic therapy. As Director of the Mayo Clinic CIM Epigenomics Program, he is leading the effort to implement epigenomic testing in the Individualized Medicine Clinic.


Send Email for Tamas Ordog

Jean-Pierre Issa, MD

Professor of Medicine and Director
Fels Institute for Cancer Research & Molecular Biology
Temple University
Philadelphia, Pennsylvania


Send Email for Jean-Pierre Issa

Ping Chi, MD, PhD

Associate Member and Associate Attending Physician
Human Oncology and Pathogenesis Program and Department of Medicine
Memorial Sloan Kettering Cancer Center
New York


Send Email for Ping Chi


Advancing Care Through Epigenomics

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Advancing Care Through Epigenomics